arrow
C

Catherine Cohet

Utrecht University
H指数:24
被引数:1,875

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An extension of the Benefit Risk Assessment of VaccinEs toolkit to evaluate Comirnaty and Spikevax vaccination in the European Union

对疫苗获益风险评估工具包的扩展,以评估欧盟境内的Comirnaty和Spikevax疫苗接种情况

2025-08-010
OAAI
Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based study

利用疫苗效益风险评估(BRAVE)工具包评估Vaxzevria在欧盟的效益与风险:一项基于人群的研究

2025-05-010
OAAI
Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomes

HLA遗传变异,新型冠状病毒肺炎疫苗抗体反应和突破性结局风险之间的关系

2024-05-133
OAAI
Risk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States
2024-02-014
OAAI
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses

在北欧国家omicron占主导地位期间,针对严重新型冠状病毒肺炎的异源第三剂量疫苗方案的比较有效性: 基于人群的队列分析

2023-07-2416
OAAI
Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US br
2022-10-2627
OAAI
Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines
2020-04-2427
OAAI